- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/39 - Heterocyclic compounds having sulfur as a ring hetero atom having oxygen atoms in the same ring
Patent holdings for IPC class A61K 31/39
Total number of patents in this class: 105
10-year publication summary
4
|
7
|
4
|
8
|
6
|
5
|
4
|
12
|
12
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Geistlich Pharma AG | 166 |
7 |
Boehringer Ingelheim International GmbH | 4748 |
5 |
CeNeRx Biopharma, Inc. | 9 |
5 |
Enanta Pharmaceuticals, Inc. | 427 |
4 |
Mydecine Innovations Group Inc. | 34 |
4 |
The Procter & Gamble Company | 22132 |
3 |
ArQule, Inc. | 138 |
3 |
The Cleveland Clinic Foundation | 1580 |
3 |
Metacrine, Inc. | 33 |
3 |
Pierre Fabre Medicament | 609 |
3 |
Cellusion Inc. | 15 |
3 |
Nihon Nohyaku Co., Ltd. | 315 |
2 |
Spectrum Pharmaceuticals, Inc. | 86 |
2 |
The University of Tokyo | 4073 |
2 |
Yeda Research and Development Co. Ltd. | 1307 |
2 |
Allergan, Inc. | 2432 |
1 |
Bayer Cropscience SA | 51 |
1 |
The Johns Hopkins University | 5543 |
1 |
University of South Florida | 1835 |
1 |
Adamed Sp. z o.o. | 23 |
1 |
Other owners | 49 |